Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion.

Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion. Abstract Text:

    jiro omataJiro Omata,kazuhiko fukatsuKazuhiko Fukatsu,chikara uenoChikara Ueno,yoshinori maeshimaYoshinori Maeshima,daizoh saitohDaizoh Saitoh,hidetaka mochizukiHidetaka Mochizuki,jiro omataJiro Omata,kazuhiko fukatsuKazuhiko Fukatsu,chikara uenoChikara Ueno,yoshinori maeshimaYoshinori Maeshima,daizoh saitohDaizoh Saitoh,hidetaka mochizukiHidetaka Mochizuki,jiro omataJiro Omata,kazuhiko fukatsuKazuhiko Fukatsu,chikara uenoChikara Ueno,yoshinori maeshimaYoshinori Maeshima,daizoh saitohDaizoh Saitoh,hidetaka mochizukiHidetaka Mochizuki,

    BACKGROUND: Glutamine (GLN) treatment prior to gut ischemia-reperfusion (I/R) reportedly preserves gut glutathione levels and gut barrier function. We hypothesized that intraluminal GLN during ischemia would also protect against gut I/R. MATERIAL AND METHODS: After randomization to control and GLN groups, mice were exposed to 75 min (Exp 1) or 50 min (Exp 2 and 3) gut I/R. One mL of 2% GLN solution was injected into the duodenal lumen at the onset of ischemia in the GLN group, whereas controls were given normal saline. In experiment 1, survival was monitored for 120 h (n = 38). In experiment 2, blood, small intestine, and liver samples were collected at 4 h after reperfusion (n = 13). Expressions of CD11a and CD11b on myeloid cells were measured. Reactive oxygen intermediate production by myeloid cells was determined with or without phorbol myristate acetate stimulation. Glutathione levels in the small intestine and liver were also evaluated. In experiment 3, hemodynamic parameters were measured before and after I/R (n = 6). RESULTS: In experiment 1, survival time in the GLN group was reduced compared with the control group. In experiment 2, GLN increased expression of CD11b and reactive oxygen intermediate with phorbol myristate acetate, compared with controls. There were no significant differences in gut or liver glutathione levels between the two groups. In experiment 3, the GLN group showed a transient but significant reduction in systolic blood pressure after reperfusion compared with the control group. CONCLUSION: Intraluminal GLN during severe gut ischemia worsens outcomes, possibly by enhancing circulating myeloid cell priming and activation, and by disturbing hemodynamics, without increasing organ glutathione levels.

    Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion. Publishing Authors By Initials

    j omataJ Omata,k fukatsuK Fukatsu,c uenoC Ueno,y maeshimaY Maeshima,d saitohD Saitoh,h mochizukiH Mochizuki,j omataJ Omata,k fukatsuK Fukatsu,c uenoC Ueno,y maeshimaY Maeshima,d saitohD Saitoh,h mochizukiH Mochizuki,j omataJ Omata,k fukatsuK Fukatsu,c uenoC Ueno,y maeshimaY Maeshima,d saitohD Saitoh,h mochizukiH Mochizuki,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: The Journal of surgical research

    VOLUME: 143

    Page Numbers: 260-4

    Journal Abbreviation: J. Surg. Res.

    ISSN: 0022-4804

    DAY: 10

    MONTH: 09

    YEAR: 2007

    Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 376340

    Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion.

    AFFILIATION: Department of Surgery, National Defense Medical College, Tokorozawa, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Surg Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Intraluminal glutamine administration during ischemia worsens survival after gut ischemia-reperfusion Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News